CAMP4 Therapeutics (CAMP) Earnings Analysis

CAMP4 Therapeutics (CAMP) next reports earnings on 2026-08-13, consensus EPS -0.24 USD. Last quarter (2026-05-07) it missed with EPS -0.32 USD vs -0.21 USD est (-52.4%). It has beaten estimates in 1/5 recent quarters (20%). Trailing P/E -1.37.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does CAMP next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate-0.24 USD
Revenue estimate0.00B

CAMP earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-07-0.32 USD-0.21 USD-52.4%Miss
2026-03-05-0.87 USD-0.31 USD-180.6%Miss
2025-11-06-0.55 USD-0.47 USD-17%Miss
2025-08-14-0.62 USD-0.67 USD+7.5%Beat
2024-11-21-24.19 USD-1.07337 USD-2153.6%Miss

Beat rate: 1/5 (20%) over reported quarters with consensus data.

CAMP valuation and analyst view

Trailing P/E-1.37
Trailing EPS-1.48991 USD
Price / book5.83
Dividend yield0.00%
Market cap0.07B
Analyst consensusBuy (17 buy / 6 hold / 1 sell)
Avg price target6.5 USD

Related research pages

Frequently asked questions

When is CAMP4 Therapeutics (CAMP)'s next earnings date?

CAMP4 Therapeutics is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.24 USD and revenue estimate of 0.00B.

Did CAMP beat earnings last quarter?

In its 2026-05-07 report, CAMP posted EPS of -0.32 USD versus a -0.21 USD estimate — a miss of 52.4%.

What is CAMP's earnings track record?

Over the last 5 reported quarters with consensus data, CAMP beat estimates 1 times (20%).

What is CAMP's current P/E ratio and EPS?

CAMP trades at a trailing P/E of -1.37 on trailing EPS of -1.4899089446570672 USD.

What do analysts rate CAMP?

Analyst consensus is "Buy" across 24 ratings (0 strong buy, 17 buy, 6 hold, 1 sell, 0 strong sell). Average 12-month price target: 6.5 USD.